Qsymia (phentermine and topiramate extended release)

Details

Basic Details

Status

Complete

Last Updated

Wednesday, August 7, 2019

Health Outcome(s)

patient characteristics

Purpose

Drug Utilization

Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR

Study Summary

Contributed important information regarding potentially viable sources of information to evaluate cardiovascular risk.

Result(s) (1)

Qsymia (Phentermine and Topiramate Extended Release) & Patient Characteristics